Global Icotinib Market Research Report 2023
Icotinib (trade name Conmana) is a highly selective, first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). Icotinib is approved for use as first-line monotherapy in patients with non-small-cell lung cancer with somatic EGFR mutations.
According to QYResearch’s new survey, global Icotinib market is projected to reach US$ 28 million in 2029, increasing from US$ 15 million in 2022, with the CAGR of 8.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Icotinib market research.
The Icotinib market is primarily driven by the demand for targeted therapies in the treatment of non-small cell lung cancer (NSCLC). Icotinib is a medication used as a tyrosine kinase inhibitor for patients with advanced NSCLC that carries EGFR mutations. The increasing prevalence of lung cancer, particularly among non-smokers and those with specific genetic mutations, contributes to market growth. Moreover, advancements in personalized medicine and the demonstrated efficacy of Icotinib in improving progression-free survival further propel adoption. However, challenges include managing the cost of targeted therapies and addressing potential drug resistance or adverse effects. Navigating patient access issues, optimizing treatment sequencing, and ensuring long-term safety are ongoing concerns. The market's success relies on continuous research in lung cancer treatment, collaborations between pharmaceutical manufacturers and oncologists, and comprehensive patient education on the benefits and potential risks of Icotinib treatment while addressing the evolving challenges associated with precision oncology and cancer treatment accessibility.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Icotinib market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global Icotinib market is projected to reach US$ 28 million in 2029, increasing from US$ 15 million in 2022, with the CAGR of 8.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Icotinib market research.
The Icotinib market is primarily driven by the demand for targeted therapies in the treatment of non-small cell lung cancer (NSCLC). Icotinib is a medication used as a tyrosine kinase inhibitor for patients with advanced NSCLC that carries EGFR mutations. The increasing prevalence of lung cancer, particularly among non-smokers and those with specific genetic mutations, contributes to market growth. Moreover, advancements in personalized medicine and the demonstrated efficacy of Icotinib in improving progression-free survival further propel adoption. However, challenges include managing the cost of targeted therapies and addressing potential drug resistance or adverse effects. Navigating patient access issues, optimizing treatment sequencing, and ensuring long-term safety are ongoing concerns. The market's success relies on continuous research in lung cancer treatment, collaborations between pharmaceutical manufacturers and oncologists, and comprehensive patient education on the benefits and potential risks of Icotinib treatment while addressing the evolving challenges associated with precision oncology and cancer treatment accessibility.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Icotinib market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Bette Pharma
- 250mg
- 125mg
- Hospital
- Drugs Store
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 ICOTINIB MARKET OVERVIEW
1.1 Product Overview and Scope of Icotinib
1.2 Icotinib Segment by Type
1.2.1 Global Icotinib Market Value Comparison by Type (2023-2029)
1.2.2 250mg
1.2.3 125mg
1.3 Icotinib Segment by Application
1.3.1 Global Icotinib Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Global Icotinib Market Size Estimates and Forecasts
1.4.1 Global Icotinib Revenue 2018-2029
1.4.2 Global Icotinib Sales 2018-2029
1.4.3 Global Icotinib Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 ICOTINIB MARKET COMPETITION BY MANUFACTURERS
2.1 Global Icotinib Sales Market Share by Manufacturers (2018-2023)
2.2 Global Icotinib Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Icotinib Average Price by Manufacturers (2018-2023)
2.4 Global Icotinib Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Icotinib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Icotinib, Product Type & Application
2.7 Icotinib Market Competitive Situation and Trends
2.7.1 Icotinib Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Icotinib Players Market Share by Revenue
2.7.3 Global Icotinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 ICOTINIB RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Icotinib Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Icotinib Global Icotinib Sales by Region: 2018-2029
3.2.1 Global Icotinib Sales by Region: 2018-2023
3.2.2 Global Icotinib Sales by Region: 2024-2029
3.3 Global Icotinib Global Icotinib Revenue by Region: 2018-2029
3.3.1 Global Icotinib Revenue by Region: 2018-2023
3.3.2 Global Icotinib Revenue by Region: 2024-2029
3.4 North America Icotinib Market Facts & Figures by Country
3.4.1 North America Icotinib Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Icotinib Sales by Country (2018-2029)
3.4.3 North America Icotinib Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Icotinib Market Facts & Figures by Country
3.5.1 Europe Icotinib Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Icotinib Sales by Country (2018-2029)
3.5.3 Europe Icotinib Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Icotinib Market Facts & Figures by Country
3.6.1 Asia Pacific Icotinib Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Icotinib Sales by Country (2018-2029)
3.6.3 Asia Pacific Icotinib Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Icotinib Market Facts & Figures by Country
3.7.1 Latin America Icotinib Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Icotinib Sales by Country (2018-2029)
3.7.3 Latin America Icotinib Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Icotinib Market Facts & Figures by Country
3.8.1 Middle East and Africa Icotinib Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Icotinib Sales by Country (2018-2029)
3.8.3 Middle East and Africa Icotinib Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Icotinib Sales by Type (2018-2029)
4.1.1 Global Icotinib Sales by Type (2018-2023)
4.1.2 Global Icotinib Sales by Type (2024-2029)
4.1.3 Global Icotinib Sales Market Share by Type (2018-2029)
4.2 Global Icotinib Revenue by Type (2018-2029)
4.2.1 Global Icotinib Revenue by Type (2018-2023)
4.2.2 Global Icotinib Revenue by Type (2024-2029)
4.2.3 Global Icotinib Revenue Market Share by Type (2018-2029)
4.3 Global Icotinib Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Icotinib Sales by Application (2018-2029)
5.1.1 Global Icotinib Sales by Application (2018-2023)
5.1.2 Global Icotinib Sales by Application (2024-2029)
5.1.3 Global Icotinib Sales Market Share by Application (2018-2029)
5.2 Global Icotinib Revenue by Application (2018-2029)
5.2.1 Global Icotinib Revenue by Application (2018-2023)
5.2.2 Global Icotinib Revenue by Application (2024-2029)
5.2.3 Global Icotinib Revenue Market Share by Application (2018-2029)
5.3 Global Icotinib Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Bette Pharma
6.1.1 Bette Pharma Corporation Information
6.1.2 Bette Pharma Description and Business Overview
6.1.3 Bette Pharma Icotinib Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bette Pharma Icotinib Product Portfolio
6.1.5 Bette Pharma Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Icotinib Industry Chain Analysis
7.2 Icotinib Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Icotinib Production Mode & Process
7.4 Icotinib Sales and Marketing
7.4.1 Icotinib Sales Channels
7.4.2 Icotinib Distributors
7.5 Icotinib Customers
8 ICOTINIB MARKET DYNAMICS
8.1 Icotinib Industry Trends
8.2 Icotinib Market Drivers
8.3 Icotinib Market Challenges
8.4 Icotinib Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Icotinib
1.2 Icotinib Segment by Type
1.2.1 Global Icotinib Market Value Comparison by Type (2023-2029)
1.2.2 250mg
1.2.3 125mg
1.3 Icotinib Segment by Application
1.3.1 Global Icotinib Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Global Icotinib Market Size Estimates and Forecasts
1.4.1 Global Icotinib Revenue 2018-2029
1.4.2 Global Icotinib Sales 2018-2029
1.4.3 Global Icotinib Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 ICOTINIB MARKET COMPETITION BY MANUFACTURERS
2.1 Global Icotinib Sales Market Share by Manufacturers (2018-2023)
2.2 Global Icotinib Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Icotinib Average Price by Manufacturers (2018-2023)
2.4 Global Icotinib Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Icotinib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Icotinib, Product Type & Application
2.7 Icotinib Market Competitive Situation and Trends
2.7.1 Icotinib Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Icotinib Players Market Share by Revenue
2.7.3 Global Icotinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 ICOTINIB RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Icotinib Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Icotinib Global Icotinib Sales by Region: 2018-2029
3.2.1 Global Icotinib Sales by Region: 2018-2023
3.2.2 Global Icotinib Sales by Region: 2024-2029
3.3 Global Icotinib Global Icotinib Revenue by Region: 2018-2029
3.3.1 Global Icotinib Revenue by Region: 2018-2023
3.3.2 Global Icotinib Revenue by Region: 2024-2029
3.4 North America Icotinib Market Facts & Figures by Country
3.4.1 North America Icotinib Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Icotinib Sales by Country (2018-2029)
3.4.3 North America Icotinib Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Icotinib Market Facts & Figures by Country
3.5.1 Europe Icotinib Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Icotinib Sales by Country (2018-2029)
3.5.3 Europe Icotinib Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Icotinib Market Facts & Figures by Country
3.6.1 Asia Pacific Icotinib Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Icotinib Sales by Country (2018-2029)
3.6.3 Asia Pacific Icotinib Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Icotinib Market Facts & Figures by Country
3.7.1 Latin America Icotinib Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Icotinib Sales by Country (2018-2029)
3.7.3 Latin America Icotinib Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Icotinib Market Facts & Figures by Country
3.8.1 Middle East and Africa Icotinib Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Icotinib Sales by Country (2018-2029)
3.8.3 Middle East and Africa Icotinib Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Icotinib Sales by Type (2018-2029)
4.1.1 Global Icotinib Sales by Type (2018-2023)
4.1.2 Global Icotinib Sales by Type (2024-2029)
4.1.3 Global Icotinib Sales Market Share by Type (2018-2029)
4.2 Global Icotinib Revenue by Type (2018-2029)
4.2.1 Global Icotinib Revenue by Type (2018-2023)
4.2.2 Global Icotinib Revenue by Type (2024-2029)
4.2.3 Global Icotinib Revenue Market Share by Type (2018-2029)
4.3 Global Icotinib Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Icotinib Sales by Application (2018-2029)
5.1.1 Global Icotinib Sales by Application (2018-2023)
5.1.2 Global Icotinib Sales by Application (2024-2029)
5.1.3 Global Icotinib Sales Market Share by Application (2018-2029)
5.2 Global Icotinib Revenue by Application (2018-2029)
5.2.1 Global Icotinib Revenue by Application (2018-2023)
5.2.2 Global Icotinib Revenue by Application (2024-2029)
5.2.3 Global Icotinib Revenue Market Share by Application (2018-2029)
5.3 Global Icotinib Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Bette Pharma
6.1.1 Bette Pharma Corporation Information
6.1.2 Bette Pharma Description and Business Overview
6.1.3 Bette Pharma Icotinib Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bette Pharma Icotinib Product Portfolio
6.1.5 Bette Pharma Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Icotinib Industry Chain Analysis
7.2 Icotinib Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Icotinib Production Mode & Process
7.4 Icotinib Sales and Marketing
7.4.1 Icotinib Sales Channels
7.4.2 Icotinib Distributors
7.5 Icotinib Customers
8 ICOTINIB MARKET DYNAMICS
8.1 Icotinib Industry Trends
8.2 Icotinib Market Drivers
8.3 Icotinib Market Challenges
8.4 Icotinib Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Icotinib Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Icotinib Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Icotinib Market Competitive Situation by Manufacturers in 2022
Table 4. Global Icotinib Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Icotinib Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Icotinib Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Icotinib Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Icotinib Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Icotinib, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Icotinib, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Icotinib, Product Type & Application
Table 12. Global Key Manufacturers of Icotinib, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Icotinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Icotinib as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Icotinib Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Icotinib Sales by Region (2018-2023) & (K Units)
Table 18. Global Icotinib Sales Market Share by Region (2018-2023)
Table 19. Global Icotinib Sales by Region (2024-2029) & (K Units)
Table 20. Global Icotinib Sales Market Share by Region (2024-2029)
Table 21. Global Icotinib Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Icotinib Revenue Market Share by Region (2018-2023)
Table 23. Global Icotinib Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Icotinib Revenue Market Share by Region (2024-2029)
Table 25. North America Icotinib Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Icotinib Sales by Country (2018-2023) & (K Units)
Table 27. North America Icotinib Sales by Country (2024-2029) & (K Units)
Table 28. North America Icotinib Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Icotinib Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Icotinib Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Icotinib Sales by Country (2018-2023) & (K Units)
Table 32. Europe Icotinib Sales by Country (2024-2029) & (K Units)
Table 33. Europe Icotinib Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Icotinib Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Icotinib Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Icotinib Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Icotinib Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Icotinib Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Icotinib Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Icotinib Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Icotinib Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Icotinib Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Icotinib Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Icotinib Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Icotinib Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Icotinib Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Icotinib Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Icotinib Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Icotinib Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Icotinib Sales (K Units) by Type (2018-2023)
Table 51. Global Icotinib Sales (K Units) by Type (2024-2029)
Table 52. Global Icotinib Sales Market Share by Type (2018-2023)
Table 53. Global Icotinib Sales Market Share by Type (2024-2029)
Table 54. Global Icotinib Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Icotinib Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Icotinib Revenue Market Share by Type (2018-2023)
Table 57. Global Icotinib Revenue Market Share by Type (2024-2029)
Table 58. Global Icotinib Price (US$/Unit) by Type (2018-2023)
Table 59. Global Icotinib Price (US$/Unit) by Type (2024-2029)
Table 60. Global Icotinib Sales (K Units) by Application (2018-2023)
Table 61. Global Icotinib Sales (K Units) by Application (2024-2029)
Table 62. Global Icotinib Sales Market Share by Application (2018-2023)
Table 63. Global Icotinib Sales Market Share by Application (2024-2029)
Table 64. Global Icotinib Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Icotinib Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Icotinib Revenue Market Share by Application (2018-2023)
Table 67. Global Icotinib Revenue Market Share by Application (2024-2029)
Table 68. Global Icotinib Price (US$/Unit) by Application (2018-2023)
Table 69. Global Icotinib Price (US$/Unit) by Application (2024-2029)
Table 70. Bette Pharma Corporation Information
Table 71. Bette Pharma Description and Business Overview
Table 72. Bette Pharma Icotinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Bette Pharma Icotinib Product
Table 74. Bette Pharma Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Icotinib Distributors List
Table 78. Icotinib Customers List
Table 79. Icotinib Market Trends
Table 80. Icotinib Market Drivers
Table 81. Icotinib Market Challenges
Table 82. Icotinib Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
Table 1. Global Icotinib Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Icotinib Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Icotinib Market Competitive Situation by Manufacturers in 2022
Table 4. Global Icotinib Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Icotinib Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Icotinib Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Icotinib Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Icotinib Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Icotinib, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Icotinib, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Icotinib, Product Type & Application
Table 12. Global Key Manufacturers of Icotinib, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Icotinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Icotinib as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Icotinib Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Icotinib Sales by Region (2018-2023) & (K Units)
Table 18. Global Icotinib Sales Market Share by Region (2018-2023)
Table 19. Global Icotinib Sales by Region (2024-2029) & (K Units)
Table 20. Global Icotinib Sales Market Share by Region (2024-2029)
Table 21. Global Icotinib Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Icotinib Revenue Market Share by Region (2018-2023)
Table 23. Global Icotinib Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Icotinib Revenue Market Share by Region (2024-2029)
Table 25. North America Icotinib Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Icotinib Sales by Country (2018-2023) & (K Units)
Table 27. North America Icotinib Sales by Country (2024-2029) & (K Units)
Table 28. North America Icotinib Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Icotinib Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Icotinib Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Icotinib Sales by Country (2018-2023) & (K Units)
Table 32. Europe Icotinib Sales by Country (2024-2029) & (K Units)
Table 33. Europe Icotinib Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Icotinib Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Icotinib Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Icotinib Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Icotinib Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Icotinib Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Icotinib Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Icotinib Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Icotinib Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Icotinib Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Icotinib Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Icotinib Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Icotinib Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Icotinib Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Icotinib Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Icotinib Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Icotinib Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Icotinib Sales (K Units) by Type (2018-2023)
Table 51. Global Icotinib Sales (K Units) by Type (2024-2029)
Table 52. Global Icotinib Sales Market Share by Type (2018-2023)
Table 53. Global Icotinib Sales Market Share by Type (2024-2029)
Table 54. Global Icotinib Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Icotinib Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Icotinib Revenue Market Share by Type (2018-2023)
Table 57. Global Icotinib Revenue Market Share by Type (2024-2029)
Table 58. Global Icotinib Price (US$/Unit) by Type (2018-2023)
Table 59. Global Icotinib Price (US$/Unit) by Type (2024-2029)
Table 60. Global Icotinib Sales (K Units) by Application (2018-2023)
Table 61. Global Icotinib Sales (K Units) by Application (2024-2029)
Table 62. Global Icotinib Sales Market Share by Application (2018-2023)
Table 63. Global Icotinib Sales Market Share by Application (2024-2029)
Table 64. Global Icotinib Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Icotinib Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Icotinib Revenue Market Share by Application (2018-2023)
Table 67. Global Icotinib Revenue Market Share by Application (2024-2029)
Table 68. Global Icotinib Price (US$/Unit) by Application (2018-2023)
Table 69. Global Icotinib Price (US$/Unit) by Application (2024-2029)
Table 70. Bette Pharma Corporation Information
Table 71. Bette Pharma Description and Business Overview
Table 72. Bette Pharma Icotinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Bette Pharma Icotinib Product
Table 74. Bette Pharma Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Icotinib Distributors List
Table 78. Icotinib Customers List
Table 79. Icotinib Market Trends
Table 80. Icotinib Market Drivers
Table 81. Icotinib Market Challenges
Table 82. Icotinib Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Icotinib
Figure 2. Global Icotinib Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Icotinib Market Share by Type in 2022 & 2029
Figure 4. 250mg Product Picture
Figure 5. 125mg Product Picture
Figure 6. Global Icotinib Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Icotinib Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Drugs Store
Figure 10. Global Icotinib Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Icotinib Market Size (2018-2029) & (US$ Million)
Figure 12. Global Icotinib Sales (2018-2029) & (K Units)
Figure 13. Global Icotinib Average Price (US$/Unit) & (2018-2029)
Figure 14. Icotinib Report Years Considered
Figure 15. Icotinib Sales Share by Manufacturers in 2022
Figure 16. Global Icotinib Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Icotinib Players: Market Share by Revenue in 2022
Figure 18. Icotinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Icotinib Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Icotinib Sales Market Share by Country (2018-2029)
Figure 21. North America Icotinib Revenue Market Share by Country (2018-2029)
Figure 22. United States Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Icotinib Sales Market Share by Country (2018-2029)
Figure 25. Europe Icotinib Revenue Market Share by Country (2018-2029)
Figure 26. Germany Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Icotinib Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Icotinib Revenue Market Share by Region (2018-2029)
Figure 33. China Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Icotinib Sales Market Share by Country (2018-2029)
Figure 43. Latin America Icotinib Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Icotinib Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Icotinib Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Icotinib by Type (2018-2029)
Figure 53. Global Revenue Market Share of Icotinib by Type (2018-2029)
Figure 54. Global Icotinib Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Icotinib by Application (2018-2029)
Figure 56. Global Revenue Market Share of Icotinib by Application (2018-2029)
Figure 57. Global Icotinib Price (US$/Unit) by Application (2018-2029)
Figure 58. Icotinib Value Chain
Figure 59. Icotinib Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Figure 1. Product Picture of Icotinib
Figure 2. Global Icotinib Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Icotinib Market Share by Type in 2022 & 2029
Figure 4. 250mg Product Picture
Figure 5. 125mg Product Picture
Figure 6. Global Icotinib Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Icotinib Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Drugs Store
Figure 10. Global Icotinib Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Icotinib Market Size (2018-2029) & (US$ Million)
Figure 12. Global Icotinib Sales (2018-2029) & (K Units)
Figure 13. Global Icotinib Average Price (US$/Unit) & (2018-2029)
Figure 14. Icotinib Report Years Considered
Figure 15. Icotinib Sales Share by Manufacturers in 2022
Figure 16. Global Icotinib Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Icotinib Players: Market Share by Revenue in 2022
Figure 18. Icotinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Icotinib Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Icotinib Sales Market Share by Country (2018-2029)
Figure 21. North America Icotinib Revenue Market Share by Country (2018-2029)
Figure 22. United States Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Icotinib Sales Market Share by Country (2018-2029)
Figure 25. Europe Icotinib Revenue Market Share by Country (2018-2029)
Figure 26. Germany Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Icotinib Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Icotinib Revenue Market Share by Region (2018-2029)
Figure 33. China Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Icotinib Sales Market Share by Country (2018-2029)
Figure 43. Latin America Icotinib Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Icotinib Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Icotinib Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Icotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Icotinib by Type (2018-2029)
Figure 53. Global Revenue Market Share of Icotinib by Type (2018-2029)
Figure 54. Global Icotinib Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Icotinib by Application (2018-2029)
Figure 56. Global Revenue Market Share of Icotinib by Application (2018-2029)
Figure 57. Global Icotinib Price (US$/Unit) by Application (2018-2029)
Figure 58. Icotinib Value Chain
Figure 59. Icotinib Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
